Your browser doesn't support javascript.
loading
A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML.
Mason, Emily F; Pozdnyakova, Olga; Roshal, Mikhail; Fathi, Amir T; Stein, Eytan M; Ferrell, P Brent; Shaver, Aaron C; Frattini, Mark; Wang, Hongfang; Hua, Lei; Mu, Jimmy; Choe, Sung; Xu, Rengyi; Almon, Caroline; Cooper, Michael; Stone, Richard M; Hasserjian, Robert P; Savona, Michael R.
Afiliação
  • Mason EF; Department of Pathology, Microbiology and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Roshal M; Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Fathi AT; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Stein EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ferrell PB; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Shaver AC; Department of Pathology, Microbiology and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Frattini M; Celgene Corporation, Summit, NJ.
  • Wang H; Agios Pharmaceuticals, Inc, Cambridge, MA.
  • Hua L; Agios Pharmaceuticals, Inc, Cambridge, MA.
  • Mu J; Agios Pharmaceuticals, Inc, Cambridge, MA.
  • Choe S; Agios Pharmaceuticals, Inc, Cambridge, MA.
  • Xu R; Agios Pharmaceuticals, Inc, Cambridge, MA.
  • Almon C; Agios Pharmaceuticals, Inc, Cambridge, MA.
  • Cooper M; Agios Pharmaceuticals, Inc, Cambridge, MA.
  • Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; and.
  • Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
Blood Adv ; 5(8): 2279-2283, 2021 04 27.
Article em En | MEDLINE | ID: mdl-33904894
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Quimioterapia de Indução Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Tunísia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Quimioterapia de Indução Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Tunísia